Home>Clinical Trials>Available Clinical Trials

Available Melanoma Sarcoma Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
E-mail: askrpci@roswellpark.org

A Randomized, Open-Label Phase 3 Trial of BMS-936558 Versus Investigators Choice in Advanced (Unresectable or Metastatic) Melanoma Patients Progressing Post Anti-CTLA-4 Therapy
(COG ARST08P1) A Pilot Study to Evaluate Novel Agents (Temozolomide and Cixutumumab [IMC-A12, Anti-IGF-IR Monoclonal Antibody, IND #100947, NSC #742460]) in Combination with Intensive Multi-Agent Interval Compressed Therap...
(TH-CR-406/SARC021) A Randomized Phase 3, Multicenter, Open Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Multicenter Selective Lymphadenectomy for Melanoma Trial II: A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melan...
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma
Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma